Kampamba M, Nelumbu N, Hikaambo C, Mudenda S, Hangoma J, Kunda M
Health Sci Rep. 2024; 7(9):e70060.
PMID: 39257911
PMC: 11386235.
DOI: 10.1002/hsr2.70060.
Liu Y, Zhang L, Chen H
BMC Public Health. 2024; 24(1):1653.
PMID: 38902766
PMC: 11191323.
DOI: 10.1186/s12889-024-19168-4.
Nelson A, Bheemraj K, Dean S, de Voux A, Hlatshwayo L, Mvududu R
Res Sq. 2023; .
PMID: 38045335
PMC: 10690321.
DOI: 10.21203/rs.3.rs-3648622/v1.
Khumalo P, Mkhonta S, Kindandi K, Matse S, Dlamini P, Tukei V
Front Reprod Health. 2023; 5:1253384.
PMID: 37965589
PMC: 10641516.
DOI: 10.3389/frph.2023.1253384.
Wagner A, Beima-Sofie K, Awuor M, Owade W, Neary J, Dettinger J
Front Reprod Health. 2023; 5:1205925.
PMID: 37799494
PMC: 10548203.
DOI: 10.3389/frph.2023.1205925.
A Patient-Centered, Combination Intervention to Support Adherence to HIV Pre-exposure Prophylaxis During Pregnancy and Breastfeeding: A Randomized Pilot Study in Malawi.
Chi B, Saidi F, Graybill L, Phanga T, Mollan K, Amico K
J Acquir Immune Defic Syndr. 2023; 95(1):42-51.
PMID: 37757844
PMC: 10873086.
DOI: 10.1097/QAI.0000000000003309.
Combination HIV prevention during pregnancy and the post-partum period in Malawi and Zambia: a mathematical modelling analysis.
Powers K, Mutale W, Rosenberg N, Graybill L, Mollan K, Freeborn K
J Int AIDS Soc. 2023; 26(7):e26128.
PMID: 37403422
PMC: 10320044.
DOI: 10.1002/jia2.26128.
Acceptability of a Combination Adherence Strategy to Support HIV Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence During Pregnancy and Breastfeeding in Malawi.
Saidi F, Phanga T, Graybill L, Mollan K, Hill L, Sibande W
AIDS Behav. 2023; 27(12):4022-4032.
PMID: 37392270
DOI: 10.1007/s10461-023-04116-x.
Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya.
Wara N, Mvududu R, Marwa M, Gomez L, Mashele N, Orrell C
J Int AIDS Soc. 2023; 26(5):e26088.
PMID: 37221983
PMC: 10206415.
DOI: 10.1002/jia2.26088.
"": Behavioural, normative, and control beliefs influencing pre-exposure prophylaxis uptake among pregnant and breastfeeding women in Zambia.
Hamoonga T, Mutale W, Hill L, Igumbor J, Chi B
Front Reprod Health. 2023; 5:1084657.
PMID: 37152481
PMC: 10154634.
DOI: 10.3389/frph.2023.1084657.
Preexposure Prophylaxis Among Pregnant and Lactating People in 18 PEPFAR-Supported Countries: A Review of HIV Strategies and Guidelines.
Abadan S, Hawryluk L, Montandon M, Flowers N, Schueller J, Eakle R
Glob Health Sci Pract. 2023; 10(6).
PMID: 36951281
PMC: 9771465.
DOI: 10.9745/GHSP-D-22-00129.
Salient beliefs and intention to use pre-exposure prophylaxis among pregnant and breastfeeding women in Zambia: Application of the Theory of Planned Behaviour.
Hamoonga T, Mutale W, Hill L, Igumbor J, Chi B
Glob Public Health. 2023; 18(1):2184483.
PMID: 36883691
PMC: 10058831.
DOI: 10.1080/17441692.2023.2184483.
Understanding PrEP decision making among pregnant women in Lilongwe, Malawi: A mixed-methods study.
Hill L, Golin C, Saidi F, Phanga T, Tseka J, Young A
J Int AIDS Soc. 2022; 25(9):e26007.
PMID: 36074034
PMC: 9454413.
DOI: 10.1002/jia2.26007.
Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
Joseph Davey D, Dovel K, Cleary S, Khadka N, Mashele N, Silliman M
BMC Public Health. 2022; 22(1):1306.
PMID: 35799121
PMC: 9264672.
DOI: 10.1186/s12889-022-13652-5.
Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
Beesham I, Dovel K, Mashele N, Bekker L, Gorbach P, Coates T
AIDS Behav. 2022; 26(9):3079-3087.
PMID: 35316471
PMC: 8938734.
DOI: 10.1007/s10461-022-03652-2.
Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.
Davey D, Bekker L, Bukusi E, Chi B, Delany-Moretlwe S, Goga A
Lancet HIV. 2022; 9(3):e214-e222.
PMID: 35090604
PMC: 9178651.
DOI: 10.1016/S2352-3018(21)00280-0.
Urgent appeal to implement pre-exposure prophylaxis for pregnant and breastfeeding women in South Africa.
Joseph Davey D, Davies N, Raphael Y, Pillay Y, Bekker L
S Afr Med J. 2021; 111(11):1038-1039.
PMID: 34949264
PMC: 9190765.
Pregnant and breastfeeding women's prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability.
Sekhon M, van der Straten A
PLoS One. 2021; 16(11):e0259779.
PMID: 34784355
PMC: 8594804.
DOI: 10.1371/journal.pone.0259779.
Combination adherence strategy to support HIV antiretroviral therapy and pre-exposure prophylaxis adherence during pregnancy and breastfeeding: protocol for a pair of pilot randomised trials.
Saidi F, Mutale W, Freeborn K, Rosenberg N, Graybill L, Maman S
BMJ Open. 2021; 11(6):e046032.
PMID: 34193491
PMC: 8246367.
DOI: 10.1136/bmjopen-2020-046032.
Tonse Pamodzi: Developing a combination strategy to support adherence to antiretroviral therapy and HIV pre-exposure prophylaxis during pregnancy and breastfeeding.
Hill L, Saidi F, Freeborn K, Amico K, Rosenberg N, Maman S
PLoS One. 2021; 16(6):e0253280.
PMID: 34170913
PMC: 8232532.
DOI: 10.1371/journal.pone.0253280.